Skip to main content
Clinical Trials/ITMCTR2200006523
ITMCTR2200006523
Not yet recruiting
Phase 1

Investigating the clinical efficacy and mechanism of Runfei Huayu recipe in treating connective tissue disease merger interstitial lung disease based on Th17/Treg glycolytic pathway

Taizhou Hospital of traditional Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Taizhou Hospital of traditional Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational study
Sex
All

Investigators

Sponsor
Taizhou Hospital of traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Meet the diagnostic criteria of traditional Chinese and western medicine for CTD\-ILD;
  • 2\. 35 years \= age \=75 years, male or female;
  • 3\. This study was approved by the ethics committee of our hospital, and informed consent was obtained from patients with signed informed consent;
  • 4\. No fertility requirement.

Exclusion Criteria

  • 1\. Patients with pulmonary tuberculosis, chronic obstructive pulmonary disease, emphysema, bronchiectasis, lung tumors, silicosis, pneumoconiosis and other lung diseases;
  • 2\. Patients with some serious primary diseases, such as digestive, respiratory, cardiovascular, hematopoietic and nervous system diseases, mental diseases, etc.;
  • 3\. Abnormal liver and kidney function, such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) exceeding 1\.5 times the normal value, blood creatinine (Scr) and urea nitrogen (BUN) any higher than the normal value;
  • 4\. Allergic constitution and allergic to clinical study medication;
  • 5\. Women who are during pregnancy, preparing for pregnancy, or during breastfeeding period.

Outcomes

Primary Outcomes

Not specified

Similar Trials